期刊文献+

代谢综合征与老年胰腺癌相关性分析 被引量:3

Relationship between metabolic syndrome and pancreatic carcinoma in seniors
下载PDF
导出
摘要 目的探讨和分析代谢综合征与老年胰腺癌的关系及老年胰腺癌患者合并代谢综合征的临床特点。方法回顾性分析2009年6月至2013年12月符合胰腺癌诊断标准且年龄大于60岁住院患者178例及同期住院的年龄、性别、身高、体质量匹配的非内分泌系统、非消化系统、非肿瘤相关疾病患者190例的临床资料,进行单因素和多因素logistic分析,分析代谢综合征及其成分与老年胰腺癌的相互关系及老年胰腺癌患者合并代谢综合征的临床特点。结果老年胰腺癌患者合并糖尿病、高三酰甘油、空腹血糖升高或代谢综合征与对照组比较差异有统计学意义,OR值分别为2.013、1.411、2.251、2.92,新发糖尿病(DM,病程≤2年)与老年胰腺癌的关联性高于长期糖尿病患者。胰腺癌组与对照组合并糖尿病者糖化血红蛋白水平与CA199均升高,两组比较差异有统计学意义(P<0.05),且胰腺癌组CA199升高与糖化血红蛋白水平关系密切。结论代谢综合征及其组成成分糖尿病、空腹血糖、三酰甘油、糖化血红蛋白是老年人患胰腺癌的独立危险因素,合并代谢综合征的老年胰腺癌患者临床特点无特异性。 Objective To study the relationship between metabolic syndrome( MS) and pancreatic carcinoma ( PC) in seniors, and to investigate the clinical characteristics of elderly patients with pancreatic cancer and the metabolic syndrome. Methods This was a retro-spective analysis of the clinical data collected from 368 inpatients admitted to this hospital from June 2009 to December 2013. These 368 in-patients, including 178 patients with pancreatic carcinoma and 190 controls without carcinoma and metabolic disease, were all older than 60. Univariate and multivariate analyses were performed to determine the risk factors of pancreatic carcinoma. The clinical characteristic analysis of older pancreatic carcinoma patients with metabolic syndrome was performed as well. Results Diabetes mellitus, serum triglyceride level, the level of higher fasting glucose and metabolic syndrome in pancreatic carcinoma group were significantly higher/severer than those in the control group. The odd ratios were 2. 013, 1. 411, 2. 251, and 2. 92, respectively. The analysis indicated that the correlation between pan-creatic cancers and new onset diabetes mellitus ( DM, course of 2 years or less) was significantly higher than that of long-term diabetes mel-litus. GHA1c and CA199 levels in both groups increased (PC vs Control, with diabetes mellitus), and the statistic comparison of both groups were significant (P<0. 05). The correlation of CA199 and GHbA1c was high in pancreatic carcinoma group. Conclusion The metabolic syndrome and its components of diabetes, fasting blood sugar, serum triglyceride level, HbA1c may be independent risk factors for pancreatic cancer in elderly patients. However, the lack of characteristic clinical features is common for elderly patients with pancreatic cancer that com-bines with metabolic syndrome.
作者 方芳
出处 《安徽医学》 2015年第7期801-804,共4页 Anhui Medical Journal
关键词 胰腺癌 代谢综合征 糖尿病 三酰甘油 糖化血红蛋白 糖类抗原199 危险因素 Pancreatic carcinoma Metabolic syndrome Diabetes mellitus Serum triglyceride Glycosylated hemoglobin A1c(HbA1c) Carbohydrate antigen-199(CA199) Risk factors
  • 相关文献

参考文献7

二级参考文献82

  • 1李士兴.永恒的遗产[J].英语文摘,2007(1):15-17. 被引量:1
  • 2Naoto Egawa,Yingsong Lin,Taku Tabata,Sawako Kuruma,Seiichi Hara,Ken Kubota,Terumi Kamisawa.ABO blood type, long-standing diabetes, and the risk of pancreatic cancer[J].World Journal of Gastroenterology,2013,19(16):2537-2542. 被引量:2
  • 3张学宏,高玉堂,邵常霞,季步天.既往疾病史与胰腺癌关系的流行病学研究[J].肿瘤,2006,26(1):37-41. 被引量:7
  • 4JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics, 2007[J]. CA Cancer J Clin, 2007, 57(1): 43-66.
  • 5BOGOEVSKI D, STRATE T, YEKEBAS E F, et al. Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination[I]. Langenbecks Arch Surg, 2008, 393(6): 91 1-91 7.
  • 6陈文彬,潘祥林主编.诊断学[M].7版.北京:人民卫生出版社,2009:381.
  • 7LI D, MORRIS J S, LIU J, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer[J]. JAMA, 2009, 301(24): 2553-2562.
  • 8KRECHLER T, NOVOTNY J, ZEMAN M, et al. Pancreatic carcinoma and diabetes mellitus[J]. Cas Lek Cesk, 2004, 143(2): 97-100.
  • 9YE W, LAGERGREN J, WEIDERPASS E, et al. Alcohol abuse and the risk of pancreatic cancer[J]. Gut, 2002, 51 (2): 236-239.
  • 10THIEBAUT A C, JIAO L, SILVERMAN D T, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study [J].J Natl Cancer Inst, 2009, 101 (14): 1001-1011.

共引文献90

同被引文献39

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3041
  • 2Denkert C, Bucher E, Hilvo M, et al. Metabolomics of human breast cancer:new approaches for tumor typing and biomarker discovery [ J ]. Genome Med ,2012,4 (4) :37.
  • 3Olivares O, Dibritz JH, King A, et al. Research into cancer metabolo- talcs:Towards a clinical metamorphosis [ J]. Semin Cell Dev Biol, 2015,43(7) :52-64.
  • 4Patel S, Ahmed S. Emerging field of metabolomics : big promise for cancer biomarker identification and drug discovery [ J ]. Pharm Biomed Anal,2015,107 (3) :63-74.
  • 5Alonso A, Marsal S, Jufiia A. Analytical methods in untargeted metabo- lomics:state of the art in 2015 [ J]. Front Bioeng Bioteehnol,2015,3 (3) :23.
  • 6Patel S, Ahmed S. Emerging field of metabolomics : Big promise for cancer biomarker identification and drug discovery [ J ]. Pharm Biomed Anal,2015,107 (3) :63455.
  • 7Bowling FG, Thomas M. Analyzing the metabolome [ J ]. Methods Mol Biol,2014,1168:31-35.
  • 8Putri SP, Yamamoto S, Tsugawa H. Current metabolomics : technologi- cal advances[J]. Biosci Bioeng,2013,116( 1 ) :9-16.
  • 9Kumar V, Dwivedi DK, Jagannathan NR. High-resolution NMR spec- troscopy of human body fluids and tissues in relation to prostate eanc- er [ J ]. NMR Biomed,2014,27 ( 1 ) :80-89.
  • 10Zhang X, Xu L, Shen J, et al. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of bloodserum[J]. Biochim Biophys Acta,2013,1832 (8) :1207-1216.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部